PHILADELPHIA, Oct. 15, 2019 /PRNewswire/ -- Members of
Manhattan-based fertility center
Reproductive Medicine Associates of New
York (RMA of New York)
presented 31 scientific abstracts at the 75th annual meeting of the
American Society for Reproductive Medicine (ASRM) in Philadelphia, Pennsylvania. Study topics
included research utilizing Next Generation DNA Sequencing,
biological causes of embryo implantation failure, and the effects
of advanced paternal age on neonatal outcome.
"I am really proud of our team for making significant
contributions to the expanding knowledge base that ultimately
drives better patient care," stated Dr. Alan B. Copperman, Co-Director of RMA of
New York, Vice Chairman of the
Department of Obstetrics and Gynecology, and Director of the
Division of Reproductive Endocrinology and Infertility at the Icahn
School of Medicine at Mount Sinai Hospital in New York.
In an award winning study, Dr. Sydney
Chang and co-authors at RMA of New
York evaluated the correlation between paternal age of
patients undergoing in vitro fertilization (IVF) and neonatal
outcomes. Ultimately, the team found no increased likelihood of
chromosomal abnormalities in embryos from older men and also showed
that the pregnancies carried by partners of older men had
comparable miscarriage rates, live birth rates, and neonatal
outcomes to those from younger men. The research study received the
prestigious Society for Male Reproduction and Urology (SMRU)
award.
Dr. Taraneh Nazem presented
research focused on improving patient outcomes by identifying
molecular markers that predict successful implantation. Her
ground-breaking research focused on the mitochondrial content of
individual cells. Dr. Nazem concluded that chromosomally normal
embryos with increased mitochondrial DNA levels have a higher
likelihood of creating healthy pregnancies. She postulated that
biological assays of mitochondrial content may soon become a
clinical marker for selecting the highest quality embryo in an IVF
cycle.
Other RMA of New York
investigator presentations examined patients with severe male
factor infertility, the effect of fibroid removal (myomectomy) on
ovarian reserve, and the increased utilization of expanded carrier
screenings (ECS) and preconception counseling in patients
undergoing IVF.
Dr. Copperman added, "This year's research spanned the gap from
the molecular, to the patient, to the population as a whole. By
accessing and interpreting genetic sequences, and by using machine
learning algorithms and artificial intelligence, we can better
inform infertile couples and can positively impact their likelihood
of success."
About Reproductive Medicine Associates of New York, LLP
Reproductive Medicine Associates of New York (RMA of New
York) is widely recognized as a global leader in
state-of-the-art reproductive medicine. Led by an integrated team
of doctors and scientists with extensive reproductive
endocrinology, fertility and urology experience and training, RMA
of New York consistently reports
to the Society for Assisted Reproductive Technology (SART) and the
Center for Disease Control and Prevention (CDC) high success rates
in the treatment of infertility. RMA of New York is committed to increasing access to
care by helping patients optimize their insurance coverage and
access financing options for treatment. RMA of New York is sensitive to the needs of the
LGBTQ+ community, women choosing single parent motherhood, and
women pursuing fertility preservation for elective indications as
well as those in need of oncofertility services. Headquartered in
midtown Manhattan, RMA of
New York has five patient care
facilities in New York, including
four facilities in Manhattan, as
well as sites in Brooklyn,
Westchester, and abroad in
Mexico City. For more information,
please visit www.rmany.com.
Media Contact:
Amanda Wolfe
Director of Marketing
awolfe@rmany.com
212-756-5777
View original content to download
multimedia:http://www.prnewswire.com/news-releases/reproductive-medicine-associates-of-new-york-presents-innovative-research-at-asrms-75th-annual-meeting-300936494.html
SOURCE Reproductive Medicine Associates of New York
